Literature DB >> 402696

Angiotensin injected into the neostriatum after learning disrupts retention performance.

J M Morgan, A Routtenberg.   

Abstract

Angiotensin II, injected into the dorsal neostriatum of rats 5 minutes after they had learned a passive avoidance task, disrupted the retention of the task 24 hours later. Identical neostriatal injections given 22 hours after learning (2 hours before retention) were without effect on retention performance. Ventral neostriatum or posterior thalamus were ineffective sites for injection of angiotensin. Injection of thyrotropin releasing hormone or lysine-8-vasopressin into the dorsal neostriatum was ineffective. These findings indicate a possible role for endogenous angiotensin in the neostriatum on retention performance and suggest potential involvement in mnemonic processes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 402696     DOI: 10.1126/science.402696

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  14 in total

1.  Blockade of AT1 receptors protects the blood-brain barrier and improves cognition in Dahl salt-sensitive hypertensive rats.

Authors:  Nicolas Pelisch; Naohisa Hosomi; Masaki Ueno; Daisuke Nakano; Hirofumi Hitomi; Masaki Mogi; Kenji Shimada; Hiroyuki Kobori; Masatsugu Horiuchi; Haruhiko Sakamoto; Masayasu Matsumoto; Masakazu Kohno; Akira Nishiyama
Journal:  Am J Hypertens       Date:  2010-12-16       Impact factor: 2.689

2.  Angiotensin II blocks memory consolidation through an AT2 receptor-dependent mechanism.

Authors:  Daniel S Kerr; Lia R M Bevilaqua; Juliana S Bonini; Janine I Rossato; Cristiano A Köhler; Jorge H Medina; Iván Izquierdo; Martín Cammarota
Journal:  Psychopharmacology (Berl)       Date:  2004-11-17       Impact factor: 4.530

3.  Brain Angiotensin II AT1 receptors are involved in the acute and long-term amphetamine-induced neurocognitive alterations.

Authors:  Natalia Andrea Marchese; Emilce Artur de laVillarmois; Osvaldo Martin Basmadjian; Mariela Fernanda Perez; Gustavo Baiardi; Claudia Bregonzio
Journal:  Psychopharmacology (Berl)       Date:  2015-11-28       Impact factor: 4.530

4.  Central effects of the angiotensin-converting enzyme inhibitor, captopril. I. Performance and subjective assessments of mood.

Authors:  D Currie; R V Lewis; D G McDevitt; A N Nicholson; N A Wright
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

Review 5.  Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets.

Authors:  John W Wright; Brent J Yamamoto; Joseph W Harding
Journal:  Prog Neurobiol       Date:  2007-11-19       Impact factor: 11.685

6.  Effect of angiotensin II and vasopressin on acquisition and extinction of conditioned avoidance in rats.

Authors:  D Baranowska; J J Braszko; K Wiśniewski
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

Review 7.  Advances in the pharmacotherapy of Alzheimer's disease.

Authors:  J C Soares; S Gershon
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

Review 8.  The renin-angiotensin-aldosterone system. Past, present and future.

Authors:  P Vecsei; E Hackenthal; D Ganten
Journal:  Klin Wochenschr       Date:  1978

Review 9.  Angiotensin converting enzyme inhibitors as potential cognitive enhancing agents.

Authors:  A M Domeney
Journal:  J Psychiatry Neurosci       Date:  1994-01       Impact factor: 6.186

10.  Angiotensin II in the hippocampus. A histochemical and electrophysiological study.

Authors:  H L Haas; D Felix; M R Celio; T Inagami
Journal:  Experientia       Date:  1980-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.